A new treatment modality in heart failure enhanced external counterpulsation (EECP).
Heart failure remains a significant health problem in the United States and in the world. Despite a surfeit of recent diagnostic and therapeutic advances, patients with heart failure remain inadequately helped. The overwhelming need for new and better therapies continues to stimulate scientists to investigate new technologies. Over the past several years the use of enhanced external counterpulsation as a treatment for chronic angina has steadily increased. Recently, its potential role in heart failure management has been shown. We review the role of enhanced external counterpulsation in heart failure management as an emerging noninvasive outpatient therapy.
Soran
Ozlem
O
Cardiovascular Institute, EECP Research Laboratory, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA. soranzo@msx.upmc.edu
D000787:Angina Pectoris / Q000209:etiology / Q000628:therapy; D015908:Counterpulsation / Q000379:methods* / Q000592:standards; D016228:Endothelial Growth Factors; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000150:complications; D016276:Ventricular Function
D016228:Endothelial Growth Factors